ILMN vs TERN · rev $4.34B vs $6.12B cap
Illumina Inc (ILMN) versus Terns Pharmaceuticals Inc (TERN) — a side-by-side from cached financials, not a winner call.
Illumina Inc (ILMN) is a diagnostics & research company listed on US.
Terns Pharmaceuticals Inc (TERN) is a biotechnology company listed on NASDAQ.
Latest reported ILMN revenue for 2025-12-28 was $4.34B. Net income was $850.0M. Revenue was down 0.7% from 2024-12-29 to 2025-12-28. ILMN currently screens at market cap $15.84B.
Latest reported TERN revenue for 2022-12-31 was $0. Net income was -$60.3M. TERN currently screens at market cap $6.12B.
ILMN currently screens at market cap $15.84B. TERN currently screens at market cap $6.12B.
Not investment advice. Open the ILMN and TERN stock pages for the full models.
Not investment advice.